Xiaolan Zhang

Papers

Total Citations

H-Index

About

Dr. Xiaolan Zhang is a leading researcher at the intersection of digital health, oncology, and cognitive science, with a primary focus on improving quality of life for cancer patients. Her most influential work centers on cancer-related cognitive impairment (CRCI) in breast cancer survivors—a debilitating condition often overlooked in clinical care. In her landmark scoping review, "Digital health interventions for cancer-related cognitive impairment in breast cancer patients" (2025), Dr. Zhang systematically mapped the emerging landscape of non-pharmacological digital therapies, demonstrating how mobile apps, web-based cognitive training, and telehealth platforms can mitigate chemotherapy-induced "brain fog." This work has already garnered 4 citations, signaling its rapid uptake by clinicians and researchers seeking scalable, accessible solutions. Dr. Zhang’s contributions are particularly notable for bridging the gap between rigorous evidence synthesis and practical, patient-centered technology design. By highlighting the potential of digital health interventions to deliver cognitive rehabilitation remotely, she has opened new avenues for supportive care in oncology. Her research not only advances scientific understanding of CRCI mechanisms but also provides a roadmap for integrating digital tools into routine cancer survivorship care, making her a pivotal voice in the future of precision health.